MARVELD2
MARVEL domain-containing protein 2
Also known as: DFNB49, FLJ30532, MALD2_HUMAN, MRVLDC2, TRIC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N4S9
- Gene
- MARVELD2
- Ensembl
- ENSG00000152939
- Chromosome
- 5
- Canonical length
- 558 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Cell Junctions
OverviewNCBI Gene
The protein encoded by this gene is a membrane protein found at the tight junctions between epithelial cells. The encoded protein helps establish epithelial barriers such as those in the organ of Corti, where these barriers are required for normal hearing. Defects in this gene are a cause of deafness autosomal recessive type 49 (DFNB49). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
558 residues, UniProt reviewed canonical sequence.
>Q8N4S9|MARVELD2
1 MSNDGRSRNR DRRYDEVPSD LPYQDTTIRT HPTLHDSERA VSADPLPPPP LPLQPPFGPD
61 FYSSDTEEPA IAPDLKPVRR FVPDSWKNFF RGKKKDPEWD KPVSDIRYIS DGVECSPPAS
121 PARPNHRSPL NSCKDPYGGS EGTFSSRKEA DAVFPRDPYG SLDRHTQTVR TYSEKVEEYN
181 LRYSYMKSWA GLLRILGVVE LLLGAGVFAC VTAYIHKDSE WYNLFGYSQP YGMGGVGGLG
241 SMYGGYYYTG PKTPFVLVVA GLAWITTIII LVLGMSMYYR TILLDSNWWP LTEFGINVAL
301 FILYMAAAIV YVNDTNRGGL CYYPLFNTPV NAVFCRVEGG QIAAMIFLFV TMIVYLISAL
361 VCLKLWRHEA ARRHREYMEQ QEINEPSLSS KRKMCEMATS GDRQRDSEVN FKELRTAKMK
421 PELLSGHIPP GHIPKPIVMP DYVAKYPVIQ TDDERERYKA VFQDQFSEYK ELSAEVQAVL
481 RKFDELDAVM SRLPHHSESR QEHERISRIH EEFKKKKNDP TFLEKKERCD YLKNKLSHIK
541 QRIQEYDKVM NWDVQGYSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MARVELD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 15 nTPM
- liver: 9.7 nTPM
- pancreas: 8.3 nTPM
- stomach: 7.6 nTPM
- kidney: 7.4 nTPM
- small intestine: 7.3 nTPM
Single-cell type
- distal convoluted tubule cells: 44 nCPM
- loop of henle epithelial cells: 43 nCPM
- renal collecting duct intercalated cells: 32 nCPM
- choroid plexus epithelial cells: 27 nCPM
- papillary tip epithelial cells: 26 nCPM
- renal connecting tubule cells: 23 nCPM
Immune cell
- memory CD4 T-cell: 0.3 nTPM
- basophil: 0.1 nTPM
- MAIT T-cell: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
Brain region
- choroid plexus: 7.6 nTPM
- thalamus: 2.7 nTPM
- pons: 2.6 nTPM
- medulla oblongata: 2.5 nTPM
- midbrain: 2.4 nTPM
- white matter: 2.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MARVELD2.
Disease | AllUniProt
Conditions MARVELD2 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 49 (DFNB49) MIM:610153
Disease | GeneticClinVar
40 pathogenic / likely-pathogenic of 257 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 49
- Rare genetic deafness
- Monogenic hearing loss
- Hearing loss, autosomal recessive
- Hearing impairment
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.18
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.2
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bicellular tight junction assembly
- cell-cell junction organization
- establishment of endothelial barrier
- sensory perception of sound
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MARVELD2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MARVELD2 as an antibody target. Whether an autoantibody or antibody against MARVELD2 could matter depends on whether native MARVELD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MARVELD2 is annotated at the cell surface, where native MARVELD2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label MARVELD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...